Literature DB >> 19763766

Uveitis associated with sarcoidosis exacerbated by etanercept therapy.

Jun Suzuki, Hiroshi Goto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763766     DOI: 10.1007/s10384-009-0691-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

1.  Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells.

Authors:  A Prasse; C G Georges; H Biller; H Hamm; H Matthys; W Luttmann; J C Virchow
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.

Authors:  Anat Galor; Victor L Perez; Jeffrey P Hammel; Careen Y Lowder
Journal:  Ophthalmology       Date:  2006-09-25       Impact factor: 12.079

Review 3.  Diverse effects of infliximab and etanercept on T lymphocytes.

Authors:  Joachim Sieper; Jan Van Den Brande
Journal:  Semin Arthritis Rheum       Date:  2005-04       Impact factor: 5.532

4.  Do tumor necrosis factor inhibitors cause uveitis? A registry-based study.

Authors:  Lyndell L Lim; Frederick W Fraunfelder; James T Rosenbaum
Journal:  Arthritis Rheum       Date:  2007-10

5.  Sarcoid-related uveitis occurring during etanercept therapy.

Authors:  P J Hashkes; I Shajrawi
Journal:  Clin Exp Rheumatol       Date:  2003 Sep-Oct       Impact factor: 4.473

  5 in total
  5 in total

Review 1.  Cytokine modulators in the treatment of sarcoidosis.

Authors:  E Bargagli; C Olivieri; P Rottoli
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

2.  Sarcoid panuveitis associated with etanercept treatment, resolving with adalimumab.

Authors:  D Dragnev; D Barr; M Kulshrestha; S Shanmugalingam
Journal:  BMJ Case Rep       Date:  2013-09-04

3.  Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature.

Authors:  Keigo Koda; Mikio Toyoshima; Tsuyoshi Nozue; Takafumi Suda
Journal:  Intern Med       Date:  2020-05-08       Impact factor: 1.271

Review 4.  Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review.

Authors:  Rosanna Dammacco; Silvana Guerriero; Giovanni Alessio; Franco Dammacco
Journal:  Int Ophthalmol       Date:  2021-11-21       Impact factor: 2.029

Review 5.  Ocular side effects of antirheumatic medications: a qualitative review.

Authors:  Clara M Castillejo Becerra; Yue Ding; Beatrice Kenol; Andrew Hendershot; Alexa Simon Meara
Journal:  BMJ Open Ophthalmol       Date:  2020-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.